
Surgical Meshes Market Report 2026
Global Outlook – By Product Type (Synthetic Surgical Meshes, Biosynthetic Surgical Meshes, Biologic Surgical Meshes, Hybrid Or Composite Surgical Meshes), By Nature (Absorbable Surgical Meshes, Non-Absorbable Surgical Meshes, Partially Absorbable Surgical Meshes), By Sales Channel (Direct Channel, In-Direct Channel), By Application (Hernia Repair, Traumatic Or Surgical Wounds, Abdominal Wall Reconstruction, Facial Surgery), By End-User (Hospitals, Ambulatory Surgical Centers, Clinics, Other End-Users) – Market Size, Trends, Strategies, and Forecast to 2035
Surgical Meshes Market Overview
• Surgical Meshes market size has reached to $2.15 billion in 2025 • Expected to grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.3% • Growth Driver: Surgical Meshes Market Growth Driven By Rising Number Of Surgical Procedures • Market Trend: Advancing Hernia Repair With Fully Absorbable Bioresorbable Mesh Technologies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Surgical Meshes Market?
A surgical meshes are medical devices made of synthetic or biological materials that is used to provide additional support to weakened or damaged tissue. It is commonly used in the repair of pelvic organ prolapse and stress urinary incontinence in women, as well as in hernia repair surgery. The main types of surgical meshes products are synthetic surgical meshes, biosynthetic surgical meshes, biologic surgical meshes, and hybrid or composite surgical meshes. Synthetic surgical meshes are medical devices made of synthetic materials used to provide additional support to weakened or damaged tissue during surgical procedures. These meshes are available various nature types such as absorbable surgical meshes, non-absorbable surgical meshes, and partially absorbable surgical meshes channeled through direct channel and in-direct channel. The various applications are hernia repair, traumatic or surgical wounds, abdominal wall reconstruction, and facial surgery used in hospitals, ambulatory surgical centers, clinics, and others.
What Is The Surgical Meshes Market Size and Share 2026?
The surgical meshes market size has grown strongly in recent years. It will grow from $2.15 billion in 2025 to $2.28 billion in 2026 at a compound annual growth rate (CAGR) of 6.2%. The growth in the historic period can be attributed to rising incidence of hernia repair and pelvic organ prolapse surgeries, increasing adoption of mesh-based tissue reinforcement techniques, availability of synthetic polypropylene and polyester mesh products, expansion of hospital surgical capacity and general surgery procedures, growing emphasis on post-surgical structural stability and recurrence reduction.What Is The Surgical Meshes Market Growth Forecast?
The surgical meshes market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to rising demand for biologic and biosynthetic surgical mesh alternatives, increasing use of hybrid and composite mesh systems in complex reconstructions, growing procedure volumes in ambulatory surgical centers and outpatient settings, expanding utilization of absorbable and partially absorbable mesh designs, rising focus on patient outcomes safety profiles and long-term durability. Major trends in the forecast period include rising adoption of surgical meshes in hernia repair and pelvic organ prolapse procedures, increasing use of synthetic biologic and hybrid mesh materials for tissue reinforcement, growing preference for absorbable non-absorbable and partially absorbable mesh variants, expansion of surgical mesh utilization across traumatic wound repair and abdominal reconstruction, increasing deployment of surgical meshes across hospitals clinics and ambulatory surgical centers.Global Surgical Meshes Market Segmentation
1) By Product Type: Synthetic Surgical Meshes, Biosynthetic Surgical Meshes, Biologic Surgical Meshes, Hybrid Or Composite Surgical Meshes 2) By Nature: Absorbable Surgical Meshes, Non-Absorbable Surgical Meshes, Partially Absorbable Surgical Meshes 3) By Sales Channel: Direct Channel, In-Direct Channel 4) By Application: Hernia Repair, Traumatic Or Surgical Wounds, Abdominal Wall Reconstruction, Facial Surgery 5) By End-User: Hospitals, Ambulatory Surgical Centers, Clinics, Other End-Users Subsegments: 1) By Synthetic Surgical Meshes: Polypropylene Mesh, Polyester Mesh, Expanded Polytetrafluoroethylene (ePTFE) Mesh 2) By Biosynthetic Surgical Meshes: Collagen-Based Mesh, Acellular Dermal Matrix 3) By Biologic Surgical Meshes: Human Tissue-Derived Mesh, Animal Tissue-Derived Mesh 4) By Hybrid Or Composite Surgical Meshes: Composite Mesh, Reinforced MeshWhat Is The Driver Of The Surgical Meshes Market?
The increasing number of surgical procedures is expected to propel the growth of the surgical meshes market going forward. A surgical procedure is a medical intervention or treatment method that involves the use of invasive techniques to address a health condition or injury. As populations age, there's a natural increase in age-related conditions requiring surgery, such as joint replacements, cataract surgery, and heart bypass procedures. Surgical meshes are necessary for surgical procedures to reinforce weakened tissues, prevent hernia recurrence, aid wound closure, augment tissues in reconstructive surgeries, facilitate minimally invasive techniques, and reduce complications such as adhesions. For instance, in June 2023, according to the International Society of Aesthetic Plastic Surgery, a Switzerland-based professional organization, the total number of surgical and non-surgical aesthetic procedures worldwide has risen to 34.9 million in 2023, up from 33.7 million in 2022. Therefore, the increasing number of surgical procedures is driving the growth of the surgical meshes industryKey Players In The Global Surgical Meshes Market
Major companies operating in the surgical meshes market are Medtronic Plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, W L Gore & Associates Inc, Mölnlycke Health Care AB, CR Bard Inc, LifeNet Health Inc, TELA Bio, LifeCell International Pvt Ltd, Lotus Surgicals Private Limited, Tepha Inc, Cousin Biotech SAS, Dipromed, Betatech Medical, Vitrex Medical A S, Pierson Surgical Ltd, Altaylar Medical, Bard Peripheral Vascular Inc, Surgenex MedicalGlobal Surgical Meshes Market Trends and Insights
Major companies operating in the surgical meshes market are developing innovative products, such as fully absorbable hernia patches, to expand treatment options and address long-term foreign-body complications. A fully absorbable hernia patch is made from bioresorbable materials that provide temporary mechanical support during healing and then gradually degrade, reducing the risk of chronic foreign-body reaction and long-term mesh-related complications. For instance, in April 2025, Becton, Dickinson and Company, a US-based medical device company, announced FDA 510(k) clearance and the commercial launch of Phasix ST Umbilical Hernia Patch, the first fully absorbable hernia patch specifically designed for umbilical hernia repair. The patch is composed of poly-4-hydroxybutyrate (P4HB) with a Sepra hydrogel barrier, uses a pocket and strap design to simplify placement and fixation, and can be deployed using the same surgical technique as traditional permanent mesh patches while offering a bioabsorbable alternative for tissue repair.What Are Latest Mergers And Acquisitions In The Surgical Meshes Market?
In February 2024, RTI Surgical, a US-based contract development and manufacturing organization (CDMO), completed the acquisition of Cook Biotech for an undisclosed amount. The acquisition aims to enhance RTI Surgical’s regenerative medicine and biomaterials capabilities by adding Cook Biotech’s porcine small intestinal submucosa (SIS) platform, expanding RTI’s allograft and xenograft product portfolio and scaling end-to-end services for soft-tissue repair. Cook Biotech is a US-based biotechnology company specializing in SIS-derived biomaterials and scaffolds used across hernia, soft-tissue and regenerative-medicine applications.Regional Outlook
North America was the largest region in the surgical mesh market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Surgical Meshes Market?
The surgical mesh market consists of sales of macroporous meshes, microporous meshes and plaited polyester meshes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Surgical Meshes Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $2.28 billion |
| Revenue Forecast In 2035 | $2.91 billion |
| Growth Rate | CAGR of 6.2% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product Type, Nature, Sales Channel, Application, End-User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Medtronic Plc, Boston Scientific Corporation, B Braun Melsungen AG, Ethicon Inc, W L Gore & Associates Inc, Mölnlycke Health Care AB, CR Bard Inc, LifeNet Health Inc, TELA Bio, LifeCell International Pvt Ltd, Lotus Surgicals Private Limited, Tepha Inc, Cousin Biotech SAS, Dipromed, Betatech Medical, Vitrex Medical A S, Pierson Surgical Ltd, Altaylar Medical, Bard Peripheral Vascular Inc, Surgenex Medical |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
